Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study
-
* Corresponding author: George D Kitas gd.kitas@dgoh.nhs.uk
Arthritis Research & Therapy 2009, 11:R110 doi:10.1186/ar2765
Accesses
- Last 30 days: 59 accesses
- Last year: 676 accesses
- All time: 2893 accesses
Cited by
BioMed Central: 2 citations
|
Letter
Tracey E Toms, Vasileios F Panoulas, Holly John, Karen MJ Douglas, George D Kitas Arthritis Research & Therapy 2009, 11:414 (21 September 2009) |
|
Letter
Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome Hennie G Raterman, Alexandre E Voskuyl, Ben AC Dijkmans, Michael T Nurmohamed Arthritis Research & Therapy 2009, 11:413 (21 September 2009) |